| 5-year overall survival | 5-year disease-specific survival | ||
---|---|---|---|---|
Parameter | HR (95% CI) | p value | HR (95% CI) | p value |
HR-HPV DNA (Positive vs. negative) | 0.46 (0.26–0.81) | 0.007 | 0.41 (0.18–0.90) | 0.027 |
p16INK4a (High vs. low) | 0.23 (0.16–0.57) | < 0.001 | 0.22 (0.09–0.52) | 0.001 |
pRB (High vs. low) | 2.54 (1.46–4.41) | 0.001 | 3.20 (1.46–6.99) | 0.004 |
Cyclin D1 (High vs. low) | 1.59 (0–2.55) | 0.053 | 1.55 (0.82–2.94) | 0.18 |
p53 (High vs. low) | 1.79 (1.12–2.86) | 0.015 | 1.52 (0.80–2.87) | 0.20 |
High p16INK4a/HR-HPV DNA positive vs. others | 0.30 (0.16–0.57) | < 0.001 | 0.26 (0.10–0.64) | 0.004 |
High p16INK4a/low pRB vs. others | 0.32 (0.18–0.45) | < 0.001 | 0.25 (0.11–0.60) | 0.002 |
High p16INK4a/low pRB/low cyclin D1/low p53 vs. others | 0.36 (0.19–0.38) | 0.001 | 0.25 (0.09–0.65) | 0.005 |